Written by By futurity.org Friday, 15 June 2012 12:23
![]() |
Two drugs frequently used to treat Alzheimer disease, donepezil and rivastigmine, are known to stimulate a group of neurons in the brain that play a major role in maintaining memory |
TThe drugs commonly used to treat memory loss in Alzheimer’s patients can make bones stronger, according to a recent study.
The findings, published in Journal of Bone and Mineral Research and highlighted in Nature Reviews: Endocrinology, could help further research into the idea that bone strength is controlled centrally within the brain.
Two drugs frequently used to treat Alzheimer disease, donepezil and rivastigmine, are known to stimulate a group of neurons in the brain that play a major role in maintaining memory. While these drugs have been widely used in the treatment of AD and other forms of dementia since the mid-1990s, their potential effect on bone biology had not been explored.
Recent research indicated that certain neurons can regulate bone metabolism and that their damage results in weaker bones. But little was known about the potential that increased activity by these neurons might have on bone.


